Implementation of the STarT Back Screening Tool

Last updated: September 12, 2018
Sponsor: Universidade Cidade de Sao Paulo
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Chronic Pain

Treatment

N/A

Clinical Study ID

NCT03671278
Unicid20
  • Ages 18-80
  • All Genders

Study Summary

The STarT Back Screening Tool (SBST) has been used in different healthcare settings in order to stratify the management of patients with low back pain. However, to date, no study has investigated the feasibility of implementing the SBST in emergency departments. The objective of this study will be to test the implementation of the SBST in the stratification of patients seeking care in emergency departments.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • We will include patients with back pain seeking care in emergency departments

Exclusion

Exclusion Criteria:

  • We will exclude patients with serious spinal pathologies (such as cancer, fractures,inflammatory and infectious diseases) as well as pregnant patients and patients withnerve root compromise.

Study Design

Total Participants: 200
Study Start date:
October 01, 2018
Estimated Completion Date:
December 31, 2019

Study Description

The Start Back Screening Tool (SBST) aims to identify and stratify primary care patients by using modifiable prognostic indicators that are relevant in clinical decision making. The objective of this study will be to test the feasibility of the implementation of the SBST in the stratification of patients seeking care in emergency departments. Study design: A prospective longitudinal cohort study with a 6-month follow-up. Intervention: At 6-weeks after baseline consultation, patients will be targeted to the specific treatment according to their subclassification in the SBST tool: education about pain neurophysiology and physical therapy. This is the first study that will provide results about logistic processes of the implementation of the SBST in the emergency sector, present feasibility data for the conduction of a large randomized controlled trial of subgroups of low back pain.